26 research outputs found
Burst-by-Burst Adaptive Decision Feedback Equalised TCM, TTCM and BICM for H.263-Assisted Wireless Video Telephony
Decision Feedback Equaliser (DFE) aided wideband Burst-by-Burst (BbB) Adaptive Trellis Coded Modulation (TCM), Turbo Trellis Coded Modulation (TTCM) and Bit-Interleaved Coded Modulation (BICM) assisted H.263-based video transceivers are proposed and characterised in performance terms when communicating over the COST 207 Typical Urban wideband fading channel. Specifically, four different modulation modes, namely 4QAM, 8PSK, 16QAM and 64QAM are invoked and protected by the above-mentioned coded modulation schemes. The TTCM assisted scheme was found to provide the best video performance, although at the cost of the highest complexity. A range of lower-complexity arrangements will also be characterised. Finally, in order to confirm these findings in an important practical environment, we have also investigated the adaptive TTCM scheme in the CDMA-based Universal Mobile Telecommunications System's (UMTS) Terrestrial Radio Access (UTRA) scenario and the good performance of adaptive TTCM scheme recorded when communicating over the COST 207 channels was retained in the UTRA environment
Recommended from our members
A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson’s disease: a study protocol for a randomised controlled trial
Abstract: Background: Parkinson’s disease (PD) affects approximately 145,519 people in the UK. Speech impairments are common with a reported prevalence of 68%, which increase physical and mental demands during conversation, reliance on family and/or carers, and the likelihood of social withdrawal reducing quality of life. In the UK, two approaches to Speech and Language Therapy (SLT) intervention are commonly available: National Health Service (NHS) SLT or Lee Silverman Voice Treatment (LSVT LOUD®). NHS SLT is tailored to the individuals’ needs per local practice typically consisting of six to eight weekly sessions; LSVT LOUD® comprises 16 sessions of individual treatment with home-based practice over 4 weeks. The evidence-base for their effectiveness is inconclusive. Methods/design: PD COMM is a phase III, multicentre, three-arm, unblinded, randomised controlled trial. Five hundred and forty-six people with idiopathic PD, reporting speech or voice problems will be enrolled. We will exclude those with a diagnosis of dementia, laryngeal pathology or those who have received SLT for speech problems in the previous 2 years. Following informed consent and completion of baseline assessments, participants will be randomised in a 1:1:1 ratio to no-intervention control, NHS SLT or LSVT LOUD® via a central computer-generated programme, using a minimisation procedure with a random element, to ensure allocation concealment. Participants randomised to the intervention groups will start treatment within 4 (NHS SLT) or 7 (LSVT LOUD®) weeks of randomisation. Primary outcome: Voice Handicap Index (VHI) total score at 3 months. Secondary outcomes include: VHI subscales, Parkinson’s Disease Questionnaire-39; Questionnaire on Acquired Speech Disorders; EuroQol-5D-5 L; ICECAP-O; resource utilisation; adverse events and carer quality of life. Mixed-methods process and health economic evaluations will take place alongside the trial. Assessments will be completed before randomisation and at 3, 6 and 12 months after randomisation. The trial started in December 2015 and will run for 77 months. Recruitment will take place in approximately 42 sites around the UK. Discussion: The trial will test the hypothesis that SLT is effective for the treatment of speech or voice problems in people with PD compared to no SLT. It will further test whether NHS SLT or LSVT LOUD® provide greater benefit and determine the cost-effectiveness of both interventions. Trial registration: International Standard Randomised Controlled Trials Number (ISRCTN) Registry, ID: 12421382. Registered on 18 April 2016
Recommended from our members
A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson’s disease: a study protocol for a randomised controlled trial
Abstract: Background: Parkinson’s disease (PD) affects approximately 145,519 people in the UK. Speech impairments are common with a reported prevalence of 68%, which increase physical and mental demands during conversation, reliance on family and/or carers, and the likelihood of social withdrawal reducing quality of life. In the UK, two approaches to Speech and Language Therapy (SLT) intervention are commonly available: National Health Service (NHS) SLT or Lee Silverman Voice Treatment (LSVT LOUD®). NHS SLT is tailored to the individuals’ needs per local practice typically consisting of six to eight weekly sessions; LSVT LOUD® comprises 16 sessions of individual treatment with home-based practice over 4 weeks. The evidence-base for their effectiveness is inconclusive. Methods/design: PD COMM is a phase III, multicentre, three-arm, unblinded, randomised controlled trial. Five hundred and forty-six people with idiopathic PD, reporting speech or voice problems will be enrolled. We will exclude those with a diagnosis of dementia, laryngeal pathology or those who have received SLT for speech problems in the previous 2 years. Following informed consent and completion of baseline assessments, participants will be randomised in a 1:1:1 ratio to no-intervention control, NHS SLT or LSVT LOUD® via a central computer-generated programme, using a minimisation procedure with a random element, to ensure allocation concealment. Participants randomised to the intervention groups will start treatment within 4 (NHS SLT) or 7 (LSVT LOUD®) weeks of randomisation. Primary outcome: Voice Handicap Index (VHI) total score at 3 months. Secondary outcomes include: VHI subscales, Parkinson’s Disease Questionnaire-39; Questionnaire on Acquired Speech Disorders; EuroQol-5D-5 L; ICECAP-O; resource utilisation; adverse events and carer quality of life. Mixed-methods process and health economic evaluations will take place alongside the trial. Assessments will be completed before randomisation and at 3, 6 and 12 months after randomisation. The trial started in December 2015 and will run for 77 months. Recruitment will take place in approximately 42 sites around the UK. Discussion: The trial will test the hypothesis that SLT is effective for the treatment of speech or voice problems in people with PD compared to no SLT. It will further test whether NHS SLT or LSVT LOUD® provide greater benefit and determine the cost-effectiveness of both interventions. Trial registration: International Standard Randomised Controlled Trials Number (ISRCTN) Registry, ID: 12421382. Registered on 18 April 2016
Time-Variant Bitrate Turbo-Coded Near-Instantaneously Adaptive OFDM-Based Interactive Videophony
A range of Adaptive Orthogonal Frequency Division Multiplex (AOFDM) video systems are proposed for interactive communications over wireless channels. The proposed constant target bitrate subband adaptive OFDM (CTBR-AOFDM) modems can provide a lower BER, than a corresponding conventional OFDM modem. The slightly more complex switched or Time-Variant Target Bit Rate (TVTBR) AOFDM modems can provide a balanced video quality performance, across a wider range of channel SNRs, maintaining the best video performance. Upon invoking the technique advocated - irrespective of the channel conditions experienced - the transceiver achieves always the best possible video quality by automatically adjusting the achievable bitrate and the associated video quality in order to match the channel quality experienced. This is achieved on a near-instantaneous basis under given propagation conditions in order to cater for the effects of pathloss, fast-fading, slow-fading, dispersion, etc. Furthermore, when the mobile is roaming in a hostile outdoor propagation environment, typically low-order, low-rate modem modes are invoked, while in benign indoor environments predominantly the high-rate, high source-signal representation quality modes are employed
Orthogonal Frequency Division Multiplex transmission of H.263 encoded video over wireless ATM networks
The video performance of the Median wireless asynchronous transfer mode (WATM) system is evaluated for a range of application scenarios using the H.263 video codec and a novel packetisation and acknowledgement scheme. The video resolutions and system parameters used are summarised in Tables 1 and 2. The required channel signal-to-noise ratio for near-unimpaired video quality is about 16dB over the dispersive worst-case channel used
Robust H.263 Video Transmission Over Mobile Channels in Interference Limited Environments
The cellular channel capacity of conventional cells is shown to vary dramatically as a function of the distance from the base station. An intelligent 7.3 kBaus adaptive videophone transceiver is contrived, in order to exploit the higher channel capacity of uninterfered cell areas and to satisfy the prevalent system optimisation criteria. The system employed an enhanced H.263-compatible video codec and it was capable of operating over a wide range of operating conditions. The proposed technique has the potential to support videotelephony over existing and future wireless systems using the H.263 video codec. The main system features are summarised in Table 1
Power-Control for Multimode Transceivers
The performance of a power-control algorithm [7] suitable for multi-mode transceivers is investigated using 1, 2 and 4 bit/symbol modems. It is shown that the algorithm is suitable for maintaining a target frame error rate, irrespective of the modulation mode employed. The transceiver parameters are summarised in Table 1, while the minimum and maximum required average transmitted powers in the cell for the different modes are given in Table 4
H261 and H263-based Programable Video Transceivers
The video quality versus bitrate performance of the H.261 and H.268codecs is characterised and a bitrate control algorithm is proposed in order to maintain a selectable near-constant video bitrate. The source codecs are operated at four different bitrates, which result in a constant symbol rate after error correction coding. This system constellation allowed us to maintain a constant video user bandwidth requirement, but benefit from improving channel conditions in terms of better video quality, when invoking more bandwidth efficient modem schemes ranging from 1 to 6 bits per symbol